Phase 1 clinical study with Bioneedles, a delivery platform for biopharmaceuticals

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 89, Issue , 2015, Pages 126-133

  Van De Wijdeven, Gijsbertus G P ^a   Hirschberg, Hoang J H B ^b   Weyers, Wolfgang ^c   Schalla, Wolfgang ^d  

^a Bioneedle Group   (Netherlands)

^b Den Dolder ^*  (Netherlands)

^c Center for Dermatopathology   (Germany)

^d Dermatopharmacological Center   (Germany)

Author keywords

Bioneedle; Biopharmaceutical; Clinical trial; Delivery platform; Polymer; Starch

Indexed keywords

POLYMER; STARCH; VACCINE;

ADULT; ARTICLE; ATMOSPHERIC PRESSURE; BIODEGRADABLE IMPLANT; BURNING SENSATION; ENERGY; FEMALE; FREEZING; HUMAN; IMPLANTATION; KINETICS; MACROPHAGE; MALE; MYALGIA; NEEDLE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRURITUS; SCAR FORMATION; SKIN PENETRATION; SYRINGE; THERMOSTABILITY; VACCINATION; VELOCITY; CLINICAL TRIAL; PHARMACEUTICS; PROCEDURES;

ABSORBABLE IMPLANTS; ADULT; BIOPHARMACEUTICS; FEMALE; HUMANS; MALE; NEEDLES; POLYMERS; SYRINGES; VACCINATION; VACCINES;

EID: 84922711334     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.11.024     Document Type: Article

References (28)

1. R.E. Kravetz Hypodermic syringe Am. J. Gastroenterol. 100 2005 2614
2. G. De Carli, D. Abiteboul, and V. Puro The importance of implementing safe sharps practices in the laboratory setting in Europe Biochem. Med. 24 2014 45 56
3. M.C. Lavoie, J.H. Verbeek, and M. Pahwa Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel Cochrane Database System. Rev. 3 2014 Cd009740
4. A.A. Afridi, A. Kumar, and R. Sayani Needle stick injuries-risk and preventive factors: a study among health care workers in tertiary care hospitals in Pakistan Global J. Health Sci. 5 2013 85 92
5. WHO best practices for injections and related procedures toolkit, WHO/EHT/10.02, 2010.
6. PATH, Giving safe injections: using auto-disable syringes for immunization, PATH/SEA/01.9, 2001.
7. J.S. Lloyd, and J.B. Milstien Auto-disable syringes for immunization: issues in technology transfer Bull. World Health Org. 77 1999 1001 1007
8. J. Lloyd, Technologies for vaccine delivery in the 21th century. A White Paper of WHO, UNICEF, USAID and PATH, in: WHO (Ed.), 2000.
9. G. Kersten, and H. Hirschberg Needle-free vaccine delivery Expert Opin. Drug Deliv. 4 2007 459 474
10. M.A. Kendall, Needle-free vaccine injection, Handbook of experimental pharmacology, 2010, pp. 193-219.
11. C. Saroja, P. Lakshmi, and S. Bhaskaran Recent trends in vaccine delivery systems: a review Int. J. Pharm. Invest. 1 2011 64 74
12. J.P. Amorij, G.F. Kersten, V. Saluja, W.F. Tonnis, W.L. Hinrichs, B. Slutter, S.M. Bal, J.A. Bouwstra, A. Huckriede, and W. Jiskoot Towards tailored vaccine delivery: needs, challenges and perspectives J. Control. Release: Off. J. Control. Release Soc. 161 2012 363 376
13. Y.C. Kim, C. Jarrahian, D. Zehrung, S. Mitragotri, and M.R. Prausnitz Delivery systems for intradermal vaccination Curr. Topics Microbiol. Immunol. 351 2012 77 112
14. M.Y. Lee, M.C. Shin, and V.C. Yang Transcutaneous antigen delivery system BMB Reports 46 2013 17 24
15. G.G. van de Wijdeven Development and assessment of mini projectiles as drug carriers J. Control. Release: Off. J. Control. Release Soc. 85 2002 145 162
16. H.J. Hirschberg, G.G. van de Wijdeven, A.B. Kelder, G.P. van den Dobbelsteen, and G.F. Kersten Bioneedles as vaccine carriers Vaccine 26 2008 2389 2397
17. H.J. Hirschberg, G.G. van de Wijdeven, H. Kraan, J.P. Amorij, and G.F. Kersten Bioneedles as alternative delivery system for hepatitis B vaccine J. Control. Release: Off. J. Control. Release Soc. 147 2010 211 217
18. P.C. Soema, G.J. Willems, K. van Twillert, G. van de Wijdeven, C.J. Boog, G.F. Kersten, and J.P. Amorij Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responses PloS one 9 2014 e92806
19. D. Christensen, T. Lindenstrom, G. van de Wijdeven, P. Andersen, and E.M. Agger Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis PloS One 5 2010 e15043
20. J.J. van Soest, and J.F. Vliegenthart Crystallinity in starch plastics: consequences for material properties Trends Biotechnol. 15 1997 208 213
21. G.P. van de Wijdeven, Implant containing destructurized starch, Patent WO2008/105663, 2008.
22. D.S. Potter, C.D.O. Potter, Drug Dlivery Technology, Patent number 8574188, 2013.
23. J. Myschik, W.T. McBurney, T. Rades, and S. Hook Immunostimulatory lipid implants containing Quil-A and DC-cholesterol Int. J. Pharm. 363 2008 91 98
24. K. van der Maaden, W. Jiskoot, and J. Bouwstra Microneedle technologies for (trans)dermal drug and vaccine delivery J. Control. Release: Off. J. Control. Release Soc. 161 2012 645 655
25. L.A. Chahl Antidromic vasodilatation and neurogenic inflammation Pharmacol. Therap. 37 1988 275 300
26. S.A. Eming, T. Krieg, and J.M. Davidson Inflammation in wound repair: molecular and cellular mechanisms J. Invest. Dermatol. 127 2007 514 525
27. R.A.F. Clark Physiology, Biochemistry, and Molecular Biology of the Skin second ed. 1991 Oxford Univ Press
28. J.W. Kalat, Biological Psychology, 11th ed., 2013.